首页 > 最新文献

Urologia Journal最新文献

英文 中文
Combination treatment of mirabegron and solifenacin versus solifenacin monotherapy in female patients with overactive bladder - A comparative study on effectiveness, safety, symptoms and quality of life and treatment adherence. mirabegron联合索非那新与索非那新单药治疗女性膀胱过动症的疗效、安全性、症状、生活质量及治疗依从性的比较研究
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-09-20 DOI: 10.1177/03915603251378596
Rathindra Nath Ray, Anshu Kumar, Ruchita Agarwal, G S Kamilya, Taquedis Noori, Monika Shah

Purpose: Compared to other overactive bladder (OAB) symptoms, incontinence has a more negative impact on quality of life and is frequently challenging to treat with antimuscarinic monotherapy. This study's goal was to compare the safety, tolerability, and effectiveness of a combination of solifenacin 5 mg and mirabegron 25 mg or 50 mg versus solifenacin 5 mg in patients with OAB.

Material and methods: In a tertiary care hospital, 258 individuals with overactive bladders participated in a randomised controlled open-label research to examine the safety and efficacy of mirabegron as a supplement to solifenacin. Randomisation was used to assign patients to one of three groups: those receiving solifenacin (5 mg) with mirabegron (25 mg), solifenacin (5 mg) plus mirabegron (50 mg) or solifenacin (5 mg) monotherapy. OABSS was used to examine the patients. A change in the OABSS from baseline to end of treatment (EOT) was the main outcome measure. This research also examined the safety and tolerability of combination treatment in comparison to solifenacin monotherapy.

Results: All combinations with solifenacin five substantially improved the OAB symptoms score as compared to solifenacin 5 mg monotherapy. When compared to solifenacin 5 mg, both combination groups significantly decreased the frequency of micturition. Although there were no dose-related differences between the combination and monotherapy groups in terms of TEAEs, blood pressure, pulse rate, PVR volume, or laboratory or ECG parameters, combination medication did result in a slightly higher frequency of constipation.

Conclusions: When compared to solifenacin 5 mg monotherapy, combination therapy with solifenacin/mirabegron markedly improved OABSS, micturition frequency, and urgency. When compared to monotherapy, all combinations were well tolerated and showed no significant extra safety concerns.

目的:与其他膀胱过动症(OAB)症状相比,尿失禁对生活质量有更大的负面影响,并且经常难以用抗毒蕈碱单药治疗。本研究的目的是比较索非那新5mg联合美拉比龙25mg或50mg与索非那新5mg在OAB患者中的安全性、耐受性和有效性。材料和方法:在一家三级保健医院,258名膀胱过度活跃的患者参加了一项随机对照开放标签研究,以检查mirabegron作为索非那新补充剂的安全性和有效性。随机化将患者分为三组:接受索利那新(5mg)联合美拉贝龙(25mg)、索利那新(5mg)加美拉贝龙(50mg)或索利那新(5mg)单药治疗的患者。采用OABSS对患者进行检查。OABSS从基线到治疗结束(EOT)的变化是主要的结果测量。该研究还检查了联合治疗与索利那新单药治疗的安全性和耐受性。结果:与索非那新5mg单药治疗相比,索非那新5的所有联合治疗均显著改善了OAB症状评分。与索利那新5mg组相比,两组的排尿频率均显著降低。尽管在teae、血压、脉搏率、PVR容积、实验室或ECG参数方面,联合用药组和单药组之间没有剂量相关的差异,但联合用药确实导致便秘的频率略高。结论:与索非那新5mg单药治疗相比,索非那新/米拉贝隆联合治疗可显著改善OABSS、排尿频率和尿急。与单药治疗相比,所有联合治疗耐受性良好,没有明显的额外安全问题。
{"title":"Combination treatment of mirabegron and solifenacin versus solifenacin monotherapy in female patients with overactive bladder - A comparative study on effectiveness, safety, symptoms and quality of life and treatment adherence.","authors":"Rathindra Nath Ray, Anshu Kumar, Ruchita Agarwal, G S Kamilya, Taquedis Noori, Monika Shah","doi":"10.1177/03915603251378596","DOIUrl":"10.1177/03915603251378596","url":null,"abstract":"<p><strong>Purpose: </strong>Compared to other overactive bladder (OAB) symptoms, incontinence has a more negative impact on quality of life and is frequently challenging to treat with antimuscarinic monotherapy. This study's goal was to compare the safety, tolerability, and effectiveness of a combination of solifenacin 5 mg and mirabegron 25 mg or 50 mg versus solifenacin 5 mg in patients with OAB.</p><p><strong>Material and methods: </strong>In a tertiary care hospital, 258 individuals with overactive bladders participated in a randomised controlled open-label research to examine the safety and efficacy of mirabegron as a supplement to solifenacin. Randomisation was used to assign patients to one of three groups: those receiving solifenacin (5 mg) with mirabegron (25 mg), solifenacin (5 mg) plus mirabegron (50 mg) or solifenacin (5 mg) monotherapy. OABSS was used to examine the patients. A change in the OABSS from baseline to end of treatment (EOT) was the main outcome measure. This research also examined the safety and tolerability of combination treatment in comparison to solifenacin monotherapy.</p><p><strong>Results: </strong>All combinations with solifenacin five substantially improved the OAB symptoms score as compared to solifenacin 5 mg monotherapy. When compared to solifenacin 5 mg, both combination groups significantly decreased the frequency of micturition. Although there were no dose-related differences between the combination and monotherapy groups in terms of TEAEs, blood pressure, pulse rate, PVR volume, or laboratory or ECG parameters, combination medication did result in a slightly higher frequency of constipation.</p><p><strong>Conclusions: </strong>When compared to solifenacin 5 mg monotherapy, combination therapy with solifenacin/mirabegron markedly improved OABSS, micturition frequency, and urgency. When compared to monotherapy, all combinations were well tolerated and showed no significant extra safety concerns.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"127-132"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145092512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of subcostal and supracostal access in percutaneous nephrolithotomy of isolated upper pole stone: A prospective randomized clinical trial. 经皮肾镜取石术中肋下和肋上取石途径的比较:一项前瞻性随机临床试验。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-10-04 DOI: 10.1177/03915603251378595
Mohammad Mehdi Hosseini, Alireza Sanati, Ali Eslahi, Dariush Irani, Abdolreza Haghpanah, Omid Khoshnood, Zeinab Karimi, Fatemeh Masjedi

Purpose: To assess and compare the safety and efficacy of supracostal and subcostal access percutaneous nephrolithotomy (PCNL) for isolated upper pole stones, we designed a prospective randomized clinical trial.

Materials and methods: A prospective randomized study of 76 patients (18-65 years old) was conducted from January 2024 to September 2024 on isolated upper calyceal renal stones at a medical teaching hospital. The eligible participants were divided into subcostal and supracostal access for PCNL groups (38 patients per group). The measured variables included age, sex, body mass index, stone size, comorbidities, procedure time, stone-free rate, hospital stay, and complications (modified Clavien Dindo grading).

Results: Of 76 patients, 47 were male and 29 female, with a mean age of 47 and 53 years for the subcostal and supracostal groups, respectively. The mean stone size was 27.38 and 28.89 mm in the two studied groups, respectively. The mean operation and fluoroscopy time, hospital stay, laboratory data, and complications had no significant difference between the two investigated groups.

Conclusion: Unlike the traditional view, supracostal access during PCNL is safe and effective and is not associated with a higher incidence of postoperative complications. However, both procedures were performed by skilled surgeons, so surgeons should have sufficient training and choose the proper method for each patient individually to minimize complications and obtain the best results. Further studies with a large number of cases are recommended.

目的:为了评估和比较肋下和肋上经皮肾镜取石术(PCNL)治疗孤立性上极结石的安全性和有效性,我们设计了一项前瞻性随机临床试验。材料与方法:于2024年1月至2024年9月在某医学教学医院对76例18-65岁的孤立肾盏上肾结石患者进行前瞻性随机研究。符合条件的参与者被分为肋下和肋上通道PCNL组(每组38例患者)。测量的变量包括年龄、性别、体重指数、结石大小、合并症、手术时间、结石无结石率、住院时间和并发症(改良的Clavien Dindo分级)。结果:76例患者中,男性47例,女性29例,肋下组和肋上组的平均年龄分别为47岁和53岁。两组的平均结石大小分别为27.38和28.89毫米。两组患者的平均手术和透视时间、住院时间、实验室数据和并发症无显著差异。结论:与传统观点不同,PCNL术中经肋上入路安全有效,且不存在较高的术后并发症发生率。然而,这两种手术都是由熟练的外科医生进行的,因此外科医生应该接受足够的培训,针对每个患者选择合适的方法,以尽量减少并发症,获得最佳效果。建议对大量病例进行进一步研究。
{"title":"Comparison of subcostal and supracostal access in percutaneous nephrolithotomy of isolated upper pole stone: A prospective randomized clinical trial.","authors":"Mohammad Mehdi Hosseini, Alireza Sanati, Ali Eslahi, Dariush Irani, Abdolreza Haghpanah, Omid Khoshnood, Zeinab Karimi, Fatemeh Masjedi","doi":"10.1177/03915603251378595","DOIUrl":"10.1177/03915603251378595","url":null,"abstract":"<p><strong>Purpose: </strong>To assess and compare the safety and efficacy of supracostal and subcostal access percutaneous nephrolithotomy (PCNL) for isolated upper pole stones, we designed a prospective randomized clinical trial.</p><p><strong>Materials and methods: </strong>A prospective randomized study of 76 patients (18-65 years old) was conducted from January 2024 to September 2024 on isolated upper calyceal renal stones at a medical teaching hospital. The eligible participants were divided into subcostal and supracostal access for PCNL groups (38 patients per group). The measured variables included age, sex, body mass index, stone size, comorbidities, procedure time, stone-free rate, hospital stay, and complications (modified Clavien Dindo grading).</p><p><strong>Results: </strong>Of 76 patients, 47 were male and 29 female, with a mean age of 47 and 53 years for the subcostal and supracostal groups, respectively. The mean stone size was 27.38 and 28.89 mm in the two studied groups, respectively. The mean operation and fluoroscopy time, hospital stay, laboratory data, and complications had no significant difference between the two investigated groups.</p><p><strong>Conclusion: </strong>Unlike the traditional view, supracostal access during PCNL is safe and effective and is not associated with a higher incidence of postoperative complications. However, both procedures were performed by skilled surgeons, so surgeons should have sufficient training and choose the proper method for each patient individually to minimize complications and obtain the best results. Further studies with a large number of cases are recommended.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"85-91"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145226250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of physiotherapy interventions in urinary incontinence and on overall quality of life in patients undergoing treatment for prostate cancer: A systematic review. 物理治疗干预对前列腺癌患者尿失禁和整体生活质量的影响:系统综述。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-09-17 DOI: 10.1177/03915603251372244
Puspangi Agarwal, Aksh Chahal, Nidhi Sharma, Richa Hirendra Rai, Yulduz Urazbaeva, Mukhayya Djumaniyazova, Abhishek Sharma

Objective: The objective of this systematic review is to extract inference from research articles published through evidence-based practice physiotherapy toward resistance training, aerobic exercises, trunk specific exercises, pelvic floor muscle training and manual therapy in managing urinary incontinence and sexual dysfunction along with strategies implemented to improve quality of life in patients undergoing treatment for prostate cancer.

Methods: The databases PubMed, Google Scholar, PEDro, MEDLINE, and Cochrane were systematically searched for this review. Two authors independently evaluated the methodological quality of the included studies using the PEDro scale to ensure reliability and validity.

Results: Total of 22 studies, comprising 1589 participants with a mean age of 62.16 ± 7.24 years were included in the review after meeting the inclusion and exclusion criteria. Physiotherapy interventions, including resistance training, aerobic exercises, trunk-specific exercises, pelvic floor muscle training, and manual therapy, demonstrated significant improvements in managing urinary incontinence among patients undergoing prostate cancer treatment. Pelvic floor muscle training was particularly effective in reducing incontinence, while resistance and aerobic training contributed to enhanced physical function and quality of life. Data extraction and verification were performed independently by two authors, with three authors cross-referencing for additional articles.

Conclusion: The clinical presentation in patients undergoing treatment for prostate cancer was found to be positively influenced by physiotherapy interventions, decreasing the symptoms of urinary incontinence and thus, improving the quality of life.

目的:本系统综述的目的是通过基于证据的物理疗法,对阻力训练、有氧运动、躯干特定运动、骨盆底肌肉训练和手工疗法治疗尿失禁和性功能障碍的研究文章进行推断,并实施改善前列腺癌治疗患者生活质量的策略。方法:系统检索PubMed、谷歌Scholar、PEDro、MEDLINE和Cochrane数据库。两位作者使用PEDro量表独立评估纳入研究的方法学质量,以确保信度和效度。结果:在符合纳入和排除标准后,共纳入22项研究,1589名平均年龄为62.16±7.24岁的受试者。物理治疗干预,包括阻力训练、有氧运动、躯干特异性运动、骨盆底肌肉训练和手工治疗,在前列腺癌治疗患者的尿失禁管理中有显著改善。盆底肌肉训练在减少尿失禁方面特别有效,而阻力和有氧训练有助于增强身体功能和生活质量。数据提取和验证由两位作者独立完成,三位作者对其他文章进行交叉参考。结论:物理治疗干预对前列腺癌患者的临床表现有积极影响,可减轻尿失禁症状,从而提高患者的生活质量。
{"title":"Impact of physiotherapy interventions in urinary incontinence and on overall quality of life in patients undergoing treatment for prostate cancer: A systematic review.","authors":"Puspangi Agarwal, Aksh Chahal, Nidhi Sharma, Richa Hirendra Rai, Yulduz Urazbaeva, Mukhayya Djumaniyazova, Abhishek Sharma","doi":"10.1177/03915603251372244","DOIUrl":"10.1177/03915603251372244","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this systematic review is to extract inference from research articles published through evidence-based practice physiotherapy toward resistance training, aerobic exercises, trunk specific exercises, pelvic floor muscle training and manual therapy in managing urinary incontinence and sexual dysfunction along with strategies implemented to improve quality of life in patients undergoing treatment for prostate cancer.</p><p><strong>Methods: </strong>The databases PubMed, Google Scholar, PEDro, MEDLINE, and Cochrane were systematically searched for this review. Two authors independently evaluated the methodological quality of the included studies using the PEDro scale to ensure reliability and validity.</p><p><strong>Results: </strong>Total of 22 studies, comprising 1589 participants with a mean age of 62.16 ± 7.24 years were included in the review after meeting the inclusion and exclusion criteria. Physiotherapy interventions, including resistance training, aerobic exercises, trunk-specific exercises, pelvic floor muscle training, and manual therapy, demonstrated significant improvements in managing urinary incontinence among patients undergoing prostate cancer treatment. Pelvic floor muscle training was particularly effective in reducing incontinence, while resistance and aerobic training contributed to enhanced physical function and quality of life. Data extraction and verification were performed independently by two authors, with three authors cross-referencing for additional articles.</p><p><strong>Conclusion: </strong>The clinical presentation in patients undergoing treatment for prostate cancer was found to be positively influenced by physiotherapy interventions, decreasing the symptoms of urinary incontinence and thus, improving the quality of life.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"10-23"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cumulative smoking exposure correlates with progression in high-grade T1 bladder cancer. 累积吸烟暴露与T1级膀胱癌进展相关
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-03 DOI: 10.1177/03915603251390744
Dor Golomb, Fahed Atamna, Mia Leonov Polak, Yuval Avda, Orit Raz

Objective: To evaluate the relationship between cumulative smoking exposure, measured in pack-years, and pathologic progression in patients with transitional cell carcinoma (TCC) of the bladder staged as high-grade T1 (HG-T1).

Patient and methods: We conducted a retrospective cohort study of patients diagnosed with HG-T1 urothelial carcinoma between 2020 and 2024. Clinical and pathological data were extracted, including age, gender, BMI, comorbidities, tumor size/location, completeness of resection, and presence of variant histology. Pathologic progression was defined based on worsening histology or stage on follow-up restaging transurethral resection of bladder tumor (TURBT). A pearson correlation and multivariate logistic regression were used to assess associations.

Results: Among the 80 patients analyzed, increasing cumulative smoking exposure, measured in pack-years, demonstrated a weak negative correlation with favorable pathology outcomes (r = -0.13). Neither tumor size nor completeness of resection showed a significant association with pathology change. Pathologic worsening was observed in 29.0% of smokers compared to 5.6% of non-smokers, with this difference approaching statistical significance (p = 0.057; OR = 7.0). When comparing non-smokers specifically to heavy smokers (⩾30 pack-years), the difference was statistically significant, with 34.4% of heavy smokers experiencing pathologic progression versus 5.6% of non-smokers (p = 0.036; OR = 8.9), indicating a strong association between heavy smoking exposure and adverse pathology.

Conclusion: Cumulative smoking exposure is an independent predictor of pathologic progression in patients with HG-T1 bladder cancer. These findings support the incorporation of smoking history into risk stratification models and underscore the importance of smoking cessation counseling in this population.

目的:评估膀胱移行细胞癌(TCC)高级别T1 (HG-T1)患者累积吸烟暴露(以包年计)与病理进展之间的关系。患者和方法:我们对2020年至2024年间诊断为HG-T1尿路上皮癌的患者进行了回顾性队列研究。提取临床和病理资料,包括年龄、性别、BMI、合并症、肿瘤大小/位置、切除的完全性和组织学变异的存在。病理进展是根据膀胱肿瘤经尿道再行膀胱肿瘤切除术(turt)的组织学恶化或分期来定义的。使用pearson相关性和多变量逻辑回归来评估相关性。结果:在分析的80例患者中,以包年为单位测量的累积吸烟暴露增加与有利的病理结果呈弱负相关(r = -0.13)。肿瘤大小和切除的完整程度与病理改变均无显著相关性。29.0%的吸烟者出现病理恶化,而非吸烟者为5.6%,差异接近统计学意义(p = 0.057; OR = 7.0)。当将非吸烟者特别与重度吸烟者(大于或等于30包年)进行比较时,差异具有统计学意义,34.4%的重度吸烟者经历病理进展,而非吸烟者为5.6% (p = 0.036; OR = 8.9),表明重度吸烟暴露与不良病理之间存在强烈关联。结论:累积吸烟暴露是HG-T1膀胱癌患者病理进展的独立预测因子。这些发现支持将吸烟史纳入风险分层模型,并强调了戒烟咨询在这一人群中的重要性。
{"title":"Cumulative smoking exposure correlates with progression in high-grade T1 bladder cancer.","authors":"Dor Golomb, Fahed Atamna, Mia Leonov Polak, Yuval Avda, Orit Raz","doi":"10.1177/03915603251390744","DOIUrl":"10.1177/03915603251390744","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the relationship between cumulative smoking exposure, measured in pack-years, and pathologic progression in patients with transitional cell carcinoma (TCC) of the bladder staged as high-grade T1 (HG-T1).</p><p><strong>Patient and methods: </strong>We conducted a retrospective cohort study of patients diagnosed with HG-T1 urothelial carcinoma between 2020 and 2024. Clinical and pathological data were extracted, including age, gender, BMI, comorbidities, tumor size/location, completeness of resection, and presence of variant histology. Pathologic progression was defined based on worsening histology or stage on follow-up restaging transurethral resection of bladder tumor (TURBT). A pearson correlation and multivariate logistic regression were used to assess associations.</p><p><strong>Results: </strong>Among the 80 patients analyzed, increasing cumulative smoking exposure, measured in pack-years, demonstrated a weak negative correlation with favorable pathology outcomes (<i>r</i> = -0.13). Neither tumor size nor completeness of resection showed a significant association with pathology change. Pathologic worsening was observed in 29.0% of smokers compared to 5.6% of non-smokers, with this difference approaching statistical significance (<i>p</i> = 0.057; <i>OR</i> = 7.0). When comparing non-smokers specifically to heavy smokers (⩾30 pack-years), the difference was statistically significant, with 34.4% of heavy smokers experiencing pathologic progression versus 5.6% of non-smokers (<i>p</i> = 0.036; <i>OR</i> = 8.9), indicating a strong association between heavy smoking exposure and adverse pathology.</p><p><strong>Conclusion: </strong>Cumulative smoking exposure is an independent predictor of pathologic progression in patients with HG-T1 bladder cancer. These findings support the incorporation of smoking history into risk stratification models and underscore the importance of smoking cessation counseling in this population.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"74-78"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145432182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of NNMT and NM23A for diagnosis of RCC: Renal Cell Carcinoma. NNMT和NM23A在肾癌诊断中的作用。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-09-28 DOI: 10.1177/03915603251376393
Soumya Ranjan Behera, Samir Swain, Mamata Jena, Zaid Ahmad Khan, Arijit Saha, Sabyasachi Panda, Pramod Kumar Mohanty, Jesse James Rani, Shashank Shekhar Prasad Mohapatra

Objective: This study investigates the diagnostic potential of nicotinamide N-methyltransferase (NNMT) and NM23A as biomarkers for renal cell carcinoma (RCC), focusing on their ability to facilitate early detection and improve diagnostic precision.

Methods: A prospective observational study was conducted over 24 months, enrolling patients with RCC, benign renal tumors, and healthy controls. Biomarker levels were measured using enzyme-linked immunosorbent assays (ELISA). Diagnostic performance was evaluated through statistical analyses, including ROC curve analysis and Mann-Whitney U tests. Additionally, machine learning models such as Random Forest and Gradient Boosting were employed to identify key predictors of RCC.

Results: NNMT and NM23A demonstrated significant diagnostic accuracy, with area under the curve (AUC) values of 0.933 and 0.915, respectively. Both biomarkers showed substantial differences across RCC, benign, and control groups (p < 0.001). Machine learning analyses highlighted NNMT as the most influential predictor for RCC diagnosis, further supporting its clinical relevance.

Conclusions: NNMT and NM23A emerge as promising non-invasive biomarkers for RCC, offering substantial diagnostic accuracy and reducing reliance on invasive procedures. Their integration into clinical workflows, supported by advanced machine learning methodologies, could transform RCC diagnostics. Further research with diverse populations is recommended to validate these findings and expand their clinical applicability.

目的:探讨烟酰胺n -甲基转移酶(NNMT)和NM23A作为肾细胞癌(RCC)生物标志物的诊断潜力,重点探讨其促进早期发现和提高诊断精度的能力。方法:一项为期24个月的前瞻性观察研究,纳入了肾细胞癌患者、良性肾肿瘤患者和健康对照。采用酶联免疫吸附试验(ELISA)测定生物标志物水平。通过统计学分析,包括ROC曲线分析和Mann-Whitney U检验,评价诊断效果。此外,采用随机森林和梯度增强等机器学习模型来识别RCC的关键预测因子。结果:NNMT和NM23A诊断准确率较高,曲线下面积(AUC)分别为0.933和0.915。结论:NNMT和NM23A有望成为RCC的非侵入性生物标志物,提供了相当高的诊断准确性,减少了对侵入性手术的依赖。在先进的机器学习方法的支持下,将它们集成到临床工作流程中,可以改变RCC诊断。建议对不同人群进行进一步研究,以验证这些发现并扩大其临床适用性。
{"title":"Role of NNMT and NM23A for diagnosis of RCC: Renal Cell Carcinoma.","authors":"Soumya Ranjan Behera, Samir Swain, Mamata Jena, Zaid Ahmad Khan, Arijit Saha, Sabyasachi Panda, Pramod Kumar Mohanty, Jesse James Rani, Shashank Shekhar Prasad Mohapatra","doi":"10.1177/03915603251376393","DOIUrl":"10.1177/03915603251376393","url":null,"abstract":"<p><strong>Objective: </strong>This study investigates the diagnostic potential of nicotinamide N-methyltransferase (NNMT) and NM23A as biomarkers for renal cell carcinoma (RCC), focusing on their ability to facilitate early detection and improve diagnostic precision.</p><p><strong>Methods: </strong>A prospective observational study was conducted over 24 months, enrolling patients with RCC, benign renal tumors, and healthy controls. Biomarker levels were measured using enzyme-linked immunosorbent assays (ELISA). Diagnostic performance was evaluated through statistical analyses, including ROC curve analysis and Mann-Whitney U tests. Additionally, machine learning models such as Random Forest and Gradient Boosting were employed to identify key predictors of RCC.</p><p><strong>Results: </strong>NNMT and NM23A demonstrated significant diagnostic accuracy, with area under the curve (AUC) values of 0.933 and 0.915, respectively. Both biomarkers showed substantial differences across RCC, benign, and control groups (<i>p</i> < 0.001). Machine learning analyses highlighted NNMT as the most influential predictor for RCC diagnosis, further supporting its clinical relevance.</p><p><strong>Conclusions: </strong>NNMT and NM23A emerge as promising non-invasive biomarkers for RCC, offering substantial diagnostic accuracy and reducing reliance on invasive procedures. Their integration into clinical workflows, supported by advanced machine learning methodologies, could transform RCC diagnostics. Further research with diverse populations is recommended to validate these findings and expand their clinical applicability.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"51-59"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal approach to residual upper pole stones after PCNL: Re-evaluating the role of RIRS with current technological developments. PCNL后残余上极结石的最佳方法:重新评估RIRS在当前技术发展中的作用。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-09-28 DOI: 10.1177/03915603251381394
Akif Erbin
{"title":"Optimal approach to residual upper pole stones after PCNL: Re-evaluating the role of RIRS with current technological developments.","authors":"Akif Erbin","doi":"10.1177/03915603251381394","DOIUrl":"10.1177/03915603251381394","url":null,"abstract":"","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"83-84"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global hotspots and trends in robotics of bladder cancer: A bibliometric and visualized analysis. 膀胱癌机器人技术的全球热点和趋势:文献计量学和可视化分析。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-04 DOI: 10.1177/03915603251388758
Xi Xu, Yan Ding, Xianjuan Guo, Jie Cao, Zhensheng Zhang

Objectives: This study examines the current state of robotics for bladder cancer in recent years, thereby enabling researchers to gain a comprehensive understanding of the field and anticipate future advancements.

Methods: A thorough search was performed on the Web of Science Core Collection (WoSCC) to identify literature about bladder cancer robotics published from 2004 to 2023. Bibliometric methods, such CiteSpace and VOSviewer, were used to examine publications, nations, institutions, journals, authors, and keywords.

Results: The 1678 papers from 2004 to 2023 showed an increasing trend in yearly publications related to robotic surgery for bladder cancer. Regarding publishing volumes and citations in this field, the United States, Roswell Park Comprehensive Cancer Center, European Urology, and Guru Khurshid A were the top nation, organization, journal, and author. Interestingly, eight of the top 10 publications in terms of citations were published in JCR1 designated scientific journals. Terms like "complications," "outcomes," "trial," "enhanced recovery," and "minimally invasive diversion" are emphasized in the study, suggesting that they are important and current research issues.

Conclusions: Recent hotspots include clinical studies evaluating outcomes and problems across various procedures, nevertheless, more work is required in the areas of minimally invasive surgery and improved recovery.

目的:本研究考察了近年来膀胱癌机器人治疗的现状,从而使研究人员能够全面了解该领域并预测未来的进展。方法:全面检索Web of Science Core Collection (WoSCC)上2004 - 2023年间发表的膀胱癌机器人相关文献。文献计量学方法,如CiteSpace和VOSviewer,用于检查出版物、国家、机构、期刊、作者和关键词。结果:2004 - 2023年1678篇膀胱癌机器人手术相关的年度论文呈现增加趋势。就该领域的出版数量和引用而言,美国、罗斯威尔公园综合癌症中心、欧洲泌尿学和Guru Khurshid A是排名第一的国家、组织、期刊和作者。有趣的是,引用次数最多的10篇论文中有8篇发表在JCR1指定的科学期刊上。“并发症”、“结果”、“试验”、“增强恢复”和“微创转移”等术语在研究中被强调,表明它们是重要的和当前的研究问题。结论:近年来的临床研究热点包括评估各种手术的结果和问题,然而,在微创手术和提高恢复方面还需要做更多的工作。
{"title":"Global hotspots and trends in robotics of bladder cancer: A bibliometric and visualized analysis.","authors":"Xi Xu, Yan Ding, Xianjuan Guo, Jie Cao, Zhensheng Zhang","doi":"10.1177/03915603251388758","DOIUrl":"10.1177/03915603251388758","url":null,"abstract":"<p><strong>Objectives: </strong>This study examines the current state of robotics for bladder cancer in recent years, thereby enabling researchers to gain a comprehensive understanding of the field and anticipate future advancements.</p><p><strong>Methods: </strong>A thorough search was performed on the Web of Science Core Collection (WoSCC) to identify literature about bladder cancer robotics published from 2004 to 2023. Bibliometric methods, such CiteSpace and VOSviewer, were used to examine publications, nations, institutions, journals, authors, and keywords.</p><p><strong>Results: </strong>The 1678 papers from 2004 to 2023 showed an increasing trend in yearly publications related to robotic surgery for bladder cancer. Regarding publishing volumes and citations in this field, the United States, Roswell Park Comprehensive Cancer Center, European Urology, and Guru Khurshid A were the top nation, organization, journal, and author. Interestingly, eight of the top 10 publications in terms of citations were published in JCR1 designated scientific journals. Terms like \"complications,\" \"outcomes,\" \"trial,\" \"enhanced recovery,\" and \"minimally invasive diversion\" are emphasized in the study, suggesting that they are important and current research issues.</p><p><strong>Conclusions: </strong>Recent hotspots include clinical studies evaluating outcomes and problems across various procedures, nevertheless, more work is required in the areas of minimally invasive surgery and improved recovery.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"102-113"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interrelation between cycling and renal and urological health: A bibliometric and systematic review. 循环与肾脏和泌尿系统健康之间的相互关系:文献计量学和系统综述。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-10-08 DOI: 10.1177/03915603251374888
Josué Daniel Segura-Arias, Carlos David Gómez-Carmona, Braulio Sánchez-Ureña, José Alexis Ugalde-Ramírez, Daniel Rojas-Valverde

This systematic and bibliometric review synthesizes current knowledge of the relationship between cycling, renal and urological health. A comprehensive search of databases from 2000 to 2023 yielded 38 relevant studies. Bibliometric analysis revealed research trends, key institutions, authors, and countries that contributed to this field. This review discusses the benefits and risks associated with cycling. Benefits included improved cardiovascular health and metabolic function. However, cycling was also associated with urological symptoms, particularly in women, and with risks of erectile dysfunction and genital numbness in both genders. Mountain biking demonstrated higher rates of scrotal pathologies. Saddle design, riding position, and cycling intensity significantly influenced perineal pressure and potential urological issues. Renal biomarkers indicated dehydration, muscle damage, and potential renal insufficiencies in cyclists, especially after prolonged and intense activity. Elevated inflammatory markers and reduced glomerular filtration rates were observed post-cycling. Sodium intake and L-tryptophan supplementation demonstrated positive effects on fatigue reduction and recovery. The review identified research gaps, including limited long-term studies and inconsistent methodologies. Future research should focus on the relationship between high-volume cycling and prostate cancer risk, optimizing bicycle design to reduce urological issues, and developing reliable methods to measure saddle pressure effects on renal health. This review provided valuable insights for cyclists, health professionals, and researchers, emphasizing the need for awareness of potential health impacts and the importance of proper equipment and techniques to minimize risks while maximizing cycling benefits.

这一系统的文献计量学综述综合了目前关于循环、肾脏和泌尿系统健康之间关系的知识。对2000年至2023年的数据库进行全面搜索,得出38项相关研究。文献计量分析揭示了该领域的研究趋势、主要机构、作者和国家。这篇综述讨论了骑车的益处和风险。益处包括改善心血管健康和代谢功能。然而,骑车也与泌尿系统症状有关,尤其是女性,而且男女都有勃起功能障碍和生殖器麻木的风险。山地自行车显示出更高的阴囊病变率。鞍座设计、骑行位置和骑行强度显著影响会阴压力和潜在的泌尿系统问题。肾脏生物标志物表明骑车者存在脱水、肌肉损伤和潜在的肾功能不全,尤其是在长时间剧烈运动后。循环后观察到炎症标志物升高和肾小球滤过率降低。钠摄入和l -色氨酸补充显示出积极的疲劳减轻和恢复作用。该综述确定了研究差距,包括有限的长期研究和不一致的方法。未来的研究应侧重于高强度骑行与前列腺癌风险之间的关系,优化自行车设计以减少泌尿系统问题,并开发可靠的方法来测量鞍座压力对肾脏健康的影响。这篇综述为骑行者、卫生专业人员和研究人员提供了有价值的见解,强调有必要认识到潜在的健康影响,以及适当的设备和技术的重要性,以最大限度地降低风险,同时最大化骑行益处。
{"title":"Interrelation between cycling and renal and urological health: A bibliometric and systematic review.","authors":"Josué Daniel Segura-Arias, Carlos David Gómez-Carmona, Braulio Sánchez-Ureña, José Alexis Ugalde-Ramírez, Daniel Rojas-Valverde","doi":"10.1177/03915603251374888","DOIUrl":"10.1177/03915603251374888","url":null,"abstract":"<p><p>This systematic and bibliometric review synthesizes current knowledge of the relationship between cycling, renal and urological health. A comprehensive search of databases from 2000 to 2023 yielded 38 relevant studies. Bibliometric analysis revealed research trends, key institutions, authors, and countries that contributed to this field. This review discusses the benefits and risks associated with cycling. Benefits included improved cardiovascular health and metabolic function. However, cycling was also associated with urological symptoms, particularly in women, and with risks of erectile dysfunction and genital numbness in both genders. Mountain biking demonstrated higher rates of scrotal pathologies. Saddle design, riding position, and cycling intensity significantly influenced perineal pressure and potential urological issues. Renal biomarkers indicated dehydration, muscle damage, and potential renal insufficiencies in cyclists, especially after prolonged and intense activity. Elevated inflammatory markers and reduced glomerular filtration rates were observed post-cycling. Sodium intake and L-tryptophan supplementation demonstrated positive effects on fatigue reduction and recovery. The review identified research gaps, including limited long-term studies and inconsistent methodologies. Future research should focus on the relationship between high-volume cycling and prostate cancer risk, optimizing bicycle design to reduce urological issues, and developing reliable methods to measure saddle pressure effects on renal health. This review provided valuable insights for cyclists, health professionals, and researchers, emphasizing the need for awareness of potential health impacts and the importance of proper equipment and techniques to minimize risks while maximizing cycling benefits.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"32-50"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic adrenalectomy: Preoperative data, surgical technique and clinical outcomes profile: A retrospective & prospective study at a tertiary care centre. 腹腔镜肾上腺切除术:术前资料,手术技术和临床结果概况:在三级保健中心的回顾性和前瞻性研究。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-04 DOI: 10.1177/03915603251387894
Sudeep Singh, Neeraj Agarwal, Navdeep Garg, Shivam Priyadarshi, Nachiket Vyas

Introduction: Laparoscopic adrenalectomy technique has the advantage of reduction in morbidity and peri-operative mortality. This technique has been established in the management of benign small masses (<5-6 cm). A dilemma exists in the management of bigger lesions or potentially malignant tumours. This study aimed to assess the procedure in terms of preoperative requirements, technique itself, the outcome and complications.

Material and methods: This mixed design (retrospective and prospective) cohort study was conducted in the Department of Urology and Renal Transplant, at one of the largest tertiary care centre of north-western India. A total of 27 patients who underwent laparoscopic adrenalectomy from January 2022 to December 2023 were included in the study. Data was collected regarding patient's demographic profile, characteristics of adrenal lesions, surgical procedures, postoperative results, and histological diagnosis.

Results: Age of patients ranged from 9 to 65 years, 15 (55.6%) were male. Common indication for laparoscopic adrenalectomy was Pheochromocytoma (40.7%), Non-Functioning Adrenal Tumour (29.6%), and Conn's syndrome (18.5%). Histopathology confirmed pheochromocytoma in 10 (37%) patients. Adenoma was found in eight (29.6%) patients. The average intra op blood loss was 174.63 ± 90.98 ml, and nine (33.3%) required post operative blood transfusion. The mean duration of surgery was 140.19 ± 26.51 min. Conversion to open surgery was required in two (7.4%) patients. Post op complications included deranged LFT (3.7%), fever (3.7%), and ileus (7.4%). The duration of the hospital stay ranged from 3 to 5 days.

Conclusion: Laparoscopic adrenalectomy can be considered a safe and effective procedure with relatively low rate of morbidity.

腹腔镜肾上腺切除术具有降低发病率和围手术期死亡率的优点。该技术已被用于良性小肿块的治疗。(材料和方法:这项混合设计(回顾性和前瞻性)队列研究是在印度西北部最大的三级保健中心之一的泌尿外科和肾脏移植科进行的。共有27名患者在2022年1月至2023年12月期间接受了腹腔镜肾上腺切除术。收集患者的人口统计资料、肾上腺病变特征、手术方法、术后结果和组织学诊断。结果:患者年龄9 ~ 65岁,男性15例(55.6%)。腹腔镜肾上腺切除术的常见适应症为嗜铬细胞瘤(40.7%)、无功能肾上腺瘤(29.6%)和康氏综合征(18.5%)。组织病理学证实10例(37%)患者为嗜铬细胞瘤。腺瘤8例(29.6%)。平均术中出血量为174.63±90.98 ml,术后需输血9例(33.3%)。平均手术时间140.19±26.51 min。2例(7.4%)患者需要转开手术。术后并发症包括肝功能紊乱(3.7%)、发热(3.7%)和肠梗阻(7.4%)。住院时间为3至5天。结论:腹腔镜肾上腺切除术是一种安全、有效、发病率低的手术方法。
{"title":"Laparoscopic adrenalectomy: Preoperative data, surgical technique and clinical outcomes profile: A retrospective & prospective study at a tertiary care centre.","authors":"Sudeep Singh, Neeraj Agarwal, Navdeep Garg, Shivam Priyadarshi, Nachiket Vyas","doi":"10.1177/03915603251387894","DOIUrl":"10.1177/03915603251387894","url":null,"abstract":"<p><strong>Introduction: </strong>Laparoscopic adrenalectomy technique has the advantage of reduction in morbidity and peri-operative mortality. This technique has been established in the management of benign small masses (<5-6 cm). A dilemma exists in the management of bigger lesions or potentially malignant tumours. This study aimed to assess the procedure in terms of preoperative requirements, technique itself, the outcome and complications.</p><p><strong>Material and methods: </strong>This mixed design (retrospective and prospective) cohort study was conducted in the Department of Urology and Renal Transplant, at one of the largest tertiary care centre of north-western India. A total of 27 patients who underwent laparoscopic adrenalectomy from January 2022 to December 2023 were included in the study. Data was collected regarding patient's demographic profile, characteristics of adrenal lesions, surgical procedures, postoperative results, and histological diagnosis.</p><p><strong>Results: </strong>Age of patients ranged from 9 to 65 years, 15 (55.6%) were male. Common indication for laparoscopic adrenalectomy was Pheochromocytoma (40.7%), Non-Functioning Adrenal Tumour (29.6%), and Conn's syndrome (18.5%). Histopathology confirmed pheochromocytoma in 10 (37%) patients. Adenoma was found in eight (29.6%) patients. The average intra op blood loss was 174.63 ± 90.98 ml, and nine (33.3%) required post operative blood transfusion. The mean duration of surgery was 140.19 ± 26.51 min. Conversion to open surgery was required in two (7.4%) patients. Post op complications included deranged LFT (3.7%), fever (3.7%), and ileus (7.4%). The duration of the hospital stay ranged from 3 to 5 days.</p><p><strong>Conclusion: </strong>Laparoscopic adrenalectomy can be considered a safe and effective procedure with relatively low rate of morbidity.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"67-73"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of intralesional steroid and hyaluronidase injection in reducing recurrence of urethral stricture after direct visual internal urethrotomy: A prospective study. 膀胱内注射类固醇和透明质酸酶在减少直接目视内尿道切开术后尿道狭窄复发中的作用:一项前瞻性研究。
IF 0.7 Q4 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-04 DOI: 10.1177/03915603251387896
Beheruk Kamalakanta, Maiti Krishnendu, Sarkar Debansu

To evaluate the role of intralesional steroid and hyaluronidase injection after direct visual internal urethrotomy in short segment (⩽2 cm) anterior urethral strictures.

Materials and methods: A prospective, interventional, randomized study involved 100 patients who underwent direct visual internal urethrotomy for short anterior urethral stricture (⩽2 cm). Patients were randomized into two groups: Group A where all patients had received intralesional triamcinolone and hyaluronidase and Group B where no intralesional injection was given after doing direct visual internal urethrotomy. Postoperatively, all patients were trained for clean intermittent self-dilatation (CISD) using a 14 Fr Foley catheter. Follow-up uroflowmetry was conducted on postoperative day 7 and at 1, 3, 6 and 12 months or when had symptoms such as poor stream of urine, acute urinary retention. Success was defined as Qmax > 12 mL/s for a minimum voided volume of 150 mL and absence of voiding symptoms.

Results: The recurrence rate was 24% in Group A compared to 46% in Group B, with a 22% absolute risk reduction (p = 0.021). The mean time to recurrence was 9.4 ± 2.5 months in Group A versus 7.5 ± 2.2 months in Group B (p = 0.039). The mean Qmax at 6 and 12 months post-DVIU were significantly higher in Group A (15.5 and 14.6 mL/s) than in Group B (14.6 and 13.6 mL/s), with p-values of 0.006 and 0.002 respectively.

Conclusion: Intralesional injection of triamcinolone and hyaluronidase following DVIU significantly reduces the recurrence rate, delays the time to recurrence and improves peak urinary flow rate in patients with short-segment (⩽2 cm) anterior urethral strictures compared to DVIU alone.

目的探讨直接目视内尿道切开术治疗短段(≥2 cm)前尿道狭窄后膀胱内注射类固醇和透明质酸酶的作用。材料和方法:一项前瞻性、介入性、随机研究纳入了100例接受直接目视内尿道切开术治疗短前尿道狭窄(≥2 cm)的患者。将患者随机分为两组:A组所有患者均行局部曲安奈德和透明质酸酶治疗;B组患者行直接目视内尿道切开术后不进行局部注射。术后,所有患者使用14 Fr Foley导管进行清洁间歇自我扩张(CISD)训练。术后第7天、第1、3、6、12个月或出现尿流不良、急性尿潴留等症状时进行随访尿流量测定。成功定义为Qmax > 12 mL/s,最小排尿量为150 mL,无排尿症状。结果:A组复发率为24%,B组为46%,绝对风险降低22% (p = 0.021)。A组平均复发时间为9.4±2.5个月,B组为7.5±2.2个月(p = 0.039)。dviu后6和12个月,A组的平均Qmax(15.5和14.6 mL/s)显著高于B组(14.6和13.6 mL/s), p值分别为0.006和0.002。结论:短段(≥2 cm)前尿道狭窄患者行DVIU后,病灶内注射曲安奈德和透明质酸酶可显著降低复发率,延缓复发时间,提高尿流峰率。
{"title":"Role of intralesional steroid and hyaluronidase injection in reducing recurrence of urethral stricture after direct visual internal urethrotomy: A prospective study.","authors":"Beheruk Kamalakanta, Maiti Krishnendu, Sarkar Debansu","doi":"10.1177/03915603251387896","DOIUrl":"10.1177/03915603251387896","url":null,"abstract":"<p><p>To evaluate the role of intralesional steroid and hyaluronidase injection after direct visual internal urethrotomy in short segment (⩽2 cm) anterior urethral strictures.</p><p><strong>Materials and methods: </strong>A prospective, interventional, randomized study involved 100 patients who underwent direct visual internal urethrotomy for short anterior urethral stricture (⩽2 cm). Patients were randomized into two groups: Group A where all patients had received intralesional triamcinolone and hyaluronidase and Group B where no intralesional injection was given after doing direct visual internal urethrotomy. Postoperatively, all patients were trained for clean intermittent self-dilatation (CISD) using a 14 Fr Foley catheter. Follow-up uroflowmetry was conducted on postoperative day 7 and at 1, 3, 6 and 12 months or when had symptoms such as poor stream of urine, acute urinary retention. Success was defined as Qmax > 12 mL/s for a minimum voided volume of 150 mL and absence of voiding symptoms.</p><p><strong>Results: </strong>The recurrence rate was 24% in Group A compared to 46% in Group B, with a 22% absolute risk reduction (p = 0.021). The mean time to recurrence was 9.4 ± 2.5 months in Group A versus 7.5 ± 2.2 months in Group B (p = 0.039). The mean Qmax at 6 and 12 months post-DVIU were significantly higher in Group A (15.5 and 14.6 mL/s) than in Group B (14.6 and 13.6 mL/s), with p-values of 0.006 and 0.002 respectively.</p><p><strong>Conclusion: </strong>Intralesional injection of triamcinolone and hyaluronidase following DVIU significantly reduces the recurrence rate, delays the time to recurrence and improves peak urinary flow rate in patients with short-segment (⩽2 cm) anterior urethral strictures compared to DVIU alone.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"121-126"},"PeriodicalIF":0.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urologia Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1